Olmesartan Medoxomil E Amlodipina Macleods (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil E Amlodipina Macleods, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and may be used in adults who require blood pressure control. GNH USA supplies Olmesartan Medoxomil E Amlodipina Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil E Amlodipina Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil and amlodipine act on cardiovascular pathways to lower blood pressure. - Hypertension: helps achieve target blood pressure and reduces cardiovascular risk. - Chronic kidney disease with hypertension: slows progression of kidney damage. - Heart failure with reduced ejection fraction: used as part of combination therapy to improve outcomes. - Post‑myocardial infarction hypertension: assists in blood pressure control after heart attack. - High‑risk cardiovascular patients: contributes to overall risk reduction when combined with other antihypertensives.

Common Side Effects: - Dizziness  - Headache  - Peripheral edema  - Flushing  - Fatigue  - Nasal congestion

Serious or Rare Side Effects: - Angio‑angina  - Severe hypotension  - Acute kidney injury  - Elevated liver enzymes  - Myocardial infarction  - Life‑threatening allergic reactions

Patients should be evaluated  - Monitor  - Adjust  - Avoid  - Caution  - Store at ambient : keep  - Store :  -  - 

t